About Steven Zeldin
I research Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's Disease), a fatal paralyzing disease that strikes seemingly randomly and most often leads to death within a few years of onset. Working from the Columbia University Irving Medical Center, I search for a clinical marker of ALS—a key tool to more easily identify it in patients, track its progress, and determine its response to medications. Apart from research, I am interested in science fiction, bouldering, and writing.